ZA882272B - Immunogenic recombinant yeast expression product and method for purifying it - Google Patents
Immunogenic recombinant yeast expression product and method for purifying itInfo
- Publication number
- ZA882272B ZA882272B ZA882272A ZA882272A ZA882272B ZA 882272 B ZA882272 B ZA 882272B ZA 882272 A ZA882272 A ZA 882272A ZA 882272 A ZA882272 A ZA 882272A ZA 882272 B ZA882272 B ZA 882272B
- Authority
- ZA
- South Africa
- Prior art keywords
- purifying
- expression product
- yeast expression
- recombinant yeast
- immunogenic recombinant
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3232687A | 1987-03-30 | 1987-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA882272B true ZA882272B (en) | 1988-09-22 |
Family
ID=21864341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA882272A ZA882272B (en) | 1987-03-30 | 1988-03-30 | Immunogenic recombinant yeast expression product and method for purifying it |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0309555A4 (xx) |
JP (1) | JPH01503514A (xx) |
AU (1) | AU617668B2 (xx) |
ES (1) | ES2009587A6 (xx) |
IL (1) | IL85905A0 (xx) |
NZ (1) | NZ224086A (xx) |
PT (2) | PT87137B (xx) |
WO (1) | WO1988007546A1 (xx) |
ZA (1) | ZA882272B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4826957A (en) * | 1985-07-12 | 1989-05-02 | New York University | Immunogenic recombinant yeast expression product and method for purifying it |
AU625713B2 (en) * | 1988-02-19 | 1992-07-16 | Microgenesys, Inc. | Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum |
SE8904100D0 (sv) * | 1989-12-05 | 1989-12-05 | Astra Ab | New analysis method |
NZ233255A (en) * | 1989-04-11 | 1993-02-25 | Chiron Corp | Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope |
US5095093A (en) * | 1990-11-06 | 1992-03-10 | The United States Of America As Represented By The Secretary Of The Navy | Protective four amino acid epitope against Plasmodium vivax malaria |
WO1993011157A1 (en) * | 1991-11-27 | 1993-06-10 | The Council Of The Queensland Institute Of Medical Research | MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4466917A (en) * | 1981-02-12 | 1984-08-21 | New York University | Malaria vaccine |
US4707357A (en) * | 1984-06-26 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor |
NZ213303A (en) * | 1984-09-12 | 1988-09-29 | Univ New York | Plasmodium protein, dna sequence and vaccine |
WO1987000533A1 (en) * | 1985-07-12 | 1987-01-29 | New York University | Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein |
US4826957A (en) * | 1985-07-12 | 1989-05-02 | New York University | Immunogenic recombinant yeast expression product and method for purifying it |
US4693994A (en) * | 1985-11-19 | 1987-09-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Protective synthetic peptide against malaria and encoding gene |
EP0252588A3 (en) * | 1986-05-12 | 1989-07-12 | Smithkline Beecham Corporation | Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine |
-
1988
- 1988-03-29 IL IL85905A patent/IL85905A0/xx unknown
- 1988-03-30 EP EP19880903724 patent/EP0309555A4/en not_active Withdrawn
- 1988-03-30 PT PT87137A patent/PT87137B/pt active IP Right Grant
- 1988-03-30 ZA ZA882272A patent/ZA882272B/xx unknown
- 1988-03-30 WO PCT/US1988/001150 patent/WO1988007546A1/en not_active Application Discontinuation
- 1988-03-30 NZ NZ224086A patent/NZ224086A/xx unknown
- 1988-03-30 ES ES8801013A patent/ES2009587A6/es not_active Expired
- 1988-03-30 AU AU15936/88A patent/AU617668B2/en not_active Ceased
- 1988-03-30 JP JP63503280A patent/JPH01503514A/ja active Pending
- 1988-04-26 PT PT87332A patent/PT87332B/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP0309555A4 (en) | 1990-04-10 |
IL85905A0 (en) | 1988-09-30 |
ES2009587A6 (es) | 1989-10-01 |
PT87137B (pt) | 1992-07-31 |
PT87332B (pt) | 1992-07-31 |
AU1593688A (en) | 1988-11-02 |
JPH01503514A (ja) | 1989-11-30 |
WO1988007546A1 (en) | 1988-10-06 |
NZ224086A (en) | 1991-02-26 |
AU617668B2 (en) | 1991-12-05 |
PT87137A (pt) | 1988-04-01 |
PT87332A (pt) | 1988-05-01 |
EP0309555A1 (en) | 1989-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8721424D0 (en) | Recombinant expression method | |
AU588431B2 (en) | Apparatus and method for continuous camlobe phasing | |
IL87815A (en) | Packaging system and method | |
HUT46363A (en) | Process for transforming human insulin-precursor into human insulin | |
AU2422388A (en) | Simplified method and apparatus for purification | |
GR871294B (en) | Oven product and preparation method therefor | |
JPS6434293A (en) | Fermentation method | |
EP0280067A3 (en) | Cyclic polycarbonate-polyepoxide reaction products and method for their preparation | |
ZA885301B (en) | Process and apparatus for fermentation and uses thereof | |
AU7440087A (en) | Process for isolating and purifying p. falciparum cs protein vaccine expressed in recombinant e. coli | |
EG18005A (en) | Composition of the activation of fermentative processes and process for the acceleration of the fermentative degradation of natural products | |
AU6524386A (en) | Method for administering vaccines and compositions therefor | |
IL85905A0 (en) | Immunogenic recombinant yeast expression product and method for purifying it | |
IL88321A0 (en) | Sialocylglycerolipids and method for preparing same | |
YU6889A (en) | Process for obtaining recombinant human interleukin-1-alpha-polypeptide | |
GB2220551B (en) | Process and means for efficient photosynthesis | |
GB2239653B (en) | Process and composition for the purification of amphotericin b | |
AU2051788A (en) | An improved method and pharmaceutical composition | |
DE3790885D2 (en) | Multicomputing system and process for driving same | |
ZA892167B (en) | Method and apparatus for shaping antiperspirant sticks and similar products | |
EP0302331A3 (en) | Esters of arylbisperfluoralkylcarbinols, method for the preparation of the same and of the arylbisperfluoralkylcarbinols in question | |
ZA859297B (en) | Process and vaccine | |
IE880951L (en) | Immunogenic recombinant yeast expression product and method¹for purifying it | |
IE880952L (en) | Immunogenic recombinant yeast expression product | |
IE871212L (en) | "process for isolating and purifying p. falciparum cs¹protein vaccine expressed in recombinant e. colt" |